Industry News
Life fellows elected to AAS
10 life scientists become fellows of the AAS. [ + ]
From bench to bedside for cancer
New cancer conference emphasising translational research will be held in Sydney in July. [ + ]
Academy of Science members announced
Seventeen of Australia’s leading scientists have been chosen to join the Australian Academy of Science.
[ + ]Megabats, microbats and the most interesting gene in the genome
Graeme O'Neill has been writing about science for almost 30 years and along the way he's developed a couple of favourite stories. One is the evolution of fruit bats, recounted in our last issue, and the other is the role of FOXP2, sometimes called the Chomsky Gene. In a sublime twist, the two stories have merged together. [ + ]
Bioscience fund joins the IIF program
The Brandon Bioscience Fund from Brandon Capital Partners has been chosen as the 11th fund to be fully licensed to operate under the Australian Government’s Innovation Investment Fund (IIF) Program.
[ + ]Protein location marks depression
US researchers say protein caught in lipid rafts affects neurotransmitter action. [ + ]
PKM2 and tumour growth
Warburg effect key to tumour growth, led by PKM2 enzyme. [ + ]
Fish fins and microRNAs
MicroRNA expression affects fin regeneration in zebrafish. [ + ]
Singapore emerging as research leader
Singapore’s research output is currently growing exponentially and will soon exceed the world average, according to recent market research.
[ + ]You say tomato ...
US crop scientists discover gene that controls fruit shape. [ + ]
Is our antiquated patent system hindering science?
Biotechnology discoveries, like the method for creating synthetic life forms, are at risk of being unduly hindered by private corporations unless patent systems are brought into the 21st century, according to an expert from The Australian National University.
[ + ]The bat, the rat and the hagfish
The March/April 2008 issue of Australian Life Scientist is out now - and it's free. [ + ]
Genome organiser rules the metastasis roost
US researchers studying a protein involved in T cell development find it promotes breast cancer growth and spread. [ + ]
Big week for Australian biotechs part II
Cytopia goes into Phase II trials for vascular disrupting agent while Benitec licensee agrees to develop RNAi-based therapy for hepatitis C. [ + ]
Jelly role in DNA methylation
Royal jelly kick-starts DNA methylation in bees, ANU researchers find. [ + ]
